Quadrant Capital Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-187
| Closed | -$6.21K | – | 2845 |
|
|
2022
Q4 | $6.21K | Sell |
187
-230
| -55% | -$7.41K | ﹤0.01% | 2145 |
|
|
2022
Q3 | $13K | Buy |
417
+256
| +159% | +$8.29K | ﹤0.01% | 1786 |
|
|
2022
Q2 | $5K | Buy |
161
+12
| +8% | +$325 | ﹤0.01% | 2003 |
|
|
2022
Q1 | $4K | Hold |
149
| – | – | ﹤0.01% | 2018 |
|
|
2021
Q4 | $3K | Hold |
149
| – | – | ﹤0.01% | 2093 |
|
|
2021
Q3 | $3K | Buy |
149
+64
| +75% | +$1.28K | ﹤0.01% | 2094 |
|
|
2021
Q2 | $2K | Buy |
85
+10
| +13% | +$212 | ﹤0.01% | 2183 |
|
|
2021
Q1 | $2K | Hold |
75
| – | – | ﹤0.01% | 2143 |
|
|
2020
Q4 | $1K | Hold |
75
| – | – | ﹤0.01% | 2241 |
|
|
2020
Q3 | $1K | Hold |
75
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q2 | $2K | Sell |
75
-4,741
| -98% | -$68.7K | ﹤0.01% | 1986 |
|
|
2020
Q1 | $41K | Buy |
+4,816
| New | +$40.5K | 0.01% | 969 |
|
|
2019
Q2 | – | Sell |
-1,874
| Closed | -$31K | – | 2429 |
|
|
2019
Q1 | $31K | Buy |
1,874
+1,528
| +442% | +$25.4K | 0.01% | 1386 |
|
|
2018
Q4 | $5K | Hold |
346
| – | – | ﹤0.01% | 1666 |
|
|
2018
Q3 | $4K | Sell |
346
-2,000
| -85% | -$31K | ﹤0.01% | 1663 |
|
|
2018
Q2 | $35K | Buy |
2,346
+2,000
| +578% | +$29.8K | 0.01% | 779 |
|
|
2018
Q1 | $4K | Sell |
346
-158,360
| -100% | -$2.34M | ﹤0.01% | 1639 |
|
|
2017
Q4 | $2.22M | Hold |
158,706
| – | – | 0.89% | 18 |
|
|
2017
Q3 | $2.27M | Hold |
158,706
| – | – | 0.94% | 18 |
|
|
2017
Q2 | $2.49M | Buy |
158,706
+223
| +0.1% | +$3.21K | 1.1% | 15 |
|
|
2017
Q1 | $2.19M | Buy |
+158,483
| New | +$2.22M | 0.96% | 17 |
|
|
2016
Q4 | – | Sell |
-53
| Closed | -$1K | – | 2093 |
|
|
2016
Q3 | $1K | Hold |
53
| – | – | ﹤0.01% | 1848 |
|
|
2016
Q2 | $1K | Hold |
53
| – | – | ﹤0.01% | 1830 |
|
|
2016
Q1 | $1K | Buy |
+53
| New | +$1.04K | ﹤0.01% | 1652 |
|
|
2015
Q4 | – | Sell |
-111,767
| Closed | -$1.91M | – | 1741 |
|
|
2015
Q3 | $1.91M | Sell |
111,767
-4,200
| -4% | -$76.8K | 1.32% | 13 |
|
|
2015
Q2 | $2.16M | Buy |
+115,967
| New | +$2.15M | 1.38% | 14 |
|
Other funds holding VIVO
Quadrant Capital Group's VIVO Position: Q1 2023 in Review
Quadrant Capital Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 187 shares — an estimated $6.21K sold.
Quadrant Capital Group first reported a position in VIVO in Q2 2015 and held it in 26 quarters. The position peaked at $2.49M in Q2 2017. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Quadrant Capital Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Quadrant Capital Group sold 187 Meridian Bioscience Inc shares in Q1 2023, an estimated $6.21K.
- Quadrant Capital Group first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 26 quarters.
- Quadrant Capital Group's Meridian Bioscience Inc position peaked at $2.49M in Q2 2017.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Quadrant Capital Group's 13F filing for Q1 2023, filed 11 May 2023.